HALO logo
halo search icon
SIGHT
Gensight Biologics SA

SIGHT · Gensight Biologics SA

0.073

EUR
-0.0024 (-3.166%)
21/10/2026 12:00:00 AM
Price change (7D)

Unlock stock Insights

Create a free account to unlock price targets, recommendations, and commentary.

Overview

Market Cap

Euro18.07M

PE

0.00

EV/EBITDA

N/A

DIV Yield

0%

Payout Ratio

0%

MQV Rating

5Very Weak

As at 21/10/2026 12:00:00 AM

Price Chart

Description

GenSight Biologics SA is a clinical-stage gene therapy company, which engages in research and development of novel therapies for mitochondrial and neurodegenerative diseases of the eye. It also focuses on central nervous system diseases. The company was founded by Bernard Jacques Alex Gilly, Botond Roska, Jean Bennett, Connie Cepko, Luk H. Vandenberghe, Serge Picaud and Jose-Alain Sahel in 2012 and is headquartered in Paris, France.

  • All-Companies
  • All-Consensus
  • HALO All
  • HALO Consensus Value
  • HALO Earnings Momentum
  • HALO Small

Key Fundamentals

EPS 3 yr Growth

-86.40%

EBITDA Margin

NaN%

Operating Cashflow

-€9m

Free Cash Flow Return

0.00%

ROIC

0.00%

Interest Coverage

-2.40

Quick Ratio

0.40

Performance

52 weeks range

Low 0.07 - 0.24

Trade Value (12mth)

US$38,129.00

1 week

3.67%

1 month

-43.97%

YTD

-35.61%

1 year

-39.84%

All time high

10.82

Additional Data

Shares Outstanding (Fully Diluted)

223m

HALO Sector

Healthcare

Next Company Report Date

19-Mar-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

EUR

Short Sell (% of issue)

0.00

Consensus score

Lock Icon/10

Recommendation

Buy

Target price

Lock Icon

Deviation

Lock Icon

Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

Halo Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Very Weak

Momentum

Price

Neutral

Earnings

Very Strong

Growth

Earnings

Weak

Dividends

Very Weak

Quality

Capital Efficiency

Strong

Balance Sheet

Very Weak

Value

Lock Icon

Consensus

Lock Icon

Yield

Lock Icon

News & Announcements

No announcements available.

See beyond the curve.

One solution for research, investing and model portfolio management.
Want to learn more?Frequently asked questions.
1
What is the current share price of Gensight Biologics SA (SIGHT:PAR)?
Halo FAQ
The current share price of Gensight Biologics SA (SIGHT:PAR) is EUR€0.07.
2
What is the 52-week high share price for Gensight Biologics SA (SIGHT:PAR)?
Halo FAQ
The 52-week high share price for Gensight Biologics SA (SIGHT:PAR) is EUR€0.24.
3
What is the 52-week low share price for Gensight Biologics SA (SIGHT:PAR)?
Halo FAQ
The 52-week low share price for Gensight Biologics SA (SIGHT:PAR) is EUR€0.07.
4
What is the dividend yield for Gensight Biologics SA (SIGHT:PAR)?
Halo FAQ
Gensight Biologics SA (SIGHT:PAR) does not pay a dividend.
5
What was Gensight Biologics SA (SIGHT:PAR) last dividend payment?
Halo FAQ
Gensight Biologics SA (SIGHT:PAR) does not pay a dividend.
6
What is the franking level for Gensight Biologics SA (SIGHT:PAR)?
Halo FAQ
Gensight Biologics SA (SIGHT:PAR) has a franking level of 0.00%.
7
In which sector is Gensight Biologics SA (SIGHT:PAR) classified?
Halo FAQ
Gensight Biologics SA (SIGHT:PAR) is classified in the Healthcare.